9. LOSS PER SHARE
SCHEDULE OF LOSS PER SHARE
| |
|
2024 |
|
|
2023 |
|
|
2022 |
|
| |
|
For the years ended December 31, |
|
| |
|
2024 |
|
|
2023 |
|
|
2022 |
|
| Loss attributable to holders of ordinary shares (USD’000): |
|
|
|
|
|
|
|
|
|
|
|
|
| Net loss from continuing operations |
|
|
(10,544 |
) |
|
|
(12,258 |
) |
|
|
(1,475 |
) |
| Net loss from discontinued operations |
|
|
- |
|
|
|
10,233 |
|
|
|
(7,132 |
) |
| Weighted average number
of ordinary shares outstanding used in computing basic (loss)/earnings per share* |
|
|
331,480 |
|
|
|
55,505 |
|
|
|
20,922 |
|
| Weighted average number
of ordinary shares outstanding used in computing diluted (loss)/earnings per share* |
|
|
345,008 |
|
|
|
64,743 |
|
|
|
20,922 |
|
| Loss per share - basic (USD) |
|
|
|
|
|
|
|
|
|
|
|
|
| - From continuing operations |
|
|
(31.81 |
) |
|
|
(220.84 |
) |
|
|
(70.50 |
) |
| - From discontinued operations |
|
|
- |
|
|
|
184.36 |
|
|
|
(340.89 |
) |
| Loss per share - diluted (USD) |
|
|
|
|
|
|
|
|
|
|
|
|
| - From continuing operations** |
|
|
(31.81 |
) |
|
|
(220.84 |
) |
|
|
(70.50 |
) |
| - From discontinued operations |
|
|
- |
|
|
|
158.06 |
|
|
|
(340.89 |
) |
| * | The
number of shares reflected the 1-for-40 reverse split effective on April 3, 2025. |
| | ** | Earnings per share for basic and diluted weighted average shares outstanding from continuing operations are the same due to anti-dilutive
feature resulting from the net loss from continuing operations for the year |
Warrants to purchase
common stock are not included in the diluted loss per share calculations when their effect is antidilutive. For the year ended December
31, 2024, about 50,070 potential shares of common stock (pre-reverse split) related to outstanding warrants and stock options
were excluded from the calculation of diluted net loss per share from continuing operations as such shares are antidilutive when there
is a loss. There were 369,522 and 370,175 pre-reverse splits, outstanding warrants and stock options were excluded from
the calculation of diluted net loss per share as such shares are antidilutive for the years ended December 31, 2023 and 2022, respectively.
|